Angela R Branche

6.7k total citations · 2 hit papers
47 papers, 1.4k citations indexed

About

Angela R Branche is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angela R Branche has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 19 papers in Infectious Diseases and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angela R Branche's work include Respiratory viral infections research (33 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Pneumonia and Respiratory Infections (10 papers). Angela R Branche is often cited by papers focused on Respiratory viral infections research (33 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Pneumonia and Respiratory Infections (10 papers). Angela R Branche collaborates with scholars based in United States, United Kingdom and Switzerland. Angela R Branche's co-authors include Ann R. Falsey, Edward E. Walsh, Jean‐Yves Pirçon, Ting Shi, Yolanda Penders, Miloje Savic, David J. Topham, Maria A. Formica, Derick R. Peterson and Lyn Finelli and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Angela R Branche

41 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis

2022 213 citations Miloje Savic, Yolanda Penders et al. Influenza and Other Respiratory Viruses profile →
Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017–2020

2021 137 citations Angela R Branche, Lisa Saiman et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela R Branche United States	17	1.2k	565	329	95	80	47	1.4k
Irene Rivero‐Calle Spain	21	787 0.7×	497 0.9×	278 0.8×	96 1.0×	77 1.0×	87	1.4k
Simon B. Drysdale United Kingdom	20	1.0k 0.9×	343 0.6×	541 1.6×	102 1.1×	112 1.4×	77	1.4k
María Hortal Uruguay	22	1.2k 1.1×	444 0.8×	185 0.6×	59 0.6×	93 1.2×	54	1.5k
Juan José García‐García Spain	22	1.3k 1.1×	288 0.5×	287 0.9×	53 0.6×	47 0.6×	115	1.7k
Leontine J. R. van Elden Netherlands	18	1.4k 1.2×	623 1.1×	330 1.0×	274 2.9×	139 1.7×	26	1.9k
Daniela de la Rosa‐Zamboni Mexico	9	1.0k 0.9×	388 0.7×	183 0.6×	97 1.0×	95 1.2×	27	1.3k
Patricia Hennessey United States	8	1.9k 1.6×	742 1.3×	723 2.2×	196 2.1×	68 0.8×	10	2.1k
Nuran Salman Türkiye	18	449 0.4×	517 0.9×	154 0.5×	68 0.7×	100 1.3×	92	1.2k
Efraim Bilavsky Israel	21	792 0.7×	551 1.0×	168 0.5×	40 0.4×	51 0.6×	99	1.4k
Mauricio Hernández United States	3	1.4k 1.2×	511 0.9×	205 0.6×	142 1.5×	57 0.7×	4	1.6k

Countries citing papers authored by Angela R Branche

Since Specialization

Citations

This map shows the geographic impact of Angela R Branche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela R Branche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela R Branche more than expected).

Fields of papers citing papers by Angela R Branche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela R Branche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela R Branche. The network helps show where Angela R Branche may publish in the future.

Co-authorship network of co-authors of Angela R Branche

This figure shows the co-authorship network connecting the top 25 collaborators of Angela R Branche. A scholar is included among the top collaborators of Angela R Branche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela R Branche. Angela R Branche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Branche, Angela R, Mark J. Mulligan, Orlando Puente, et al.. (2025). A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults. Vaccines. 13(4). 383–383. 3 indexed citations

Branche, Angela R, Ann R. Falsey, Lisa Saiman, et al.. (2025). Respiratory Syncytial Virus Risk Assessment in Adults: Implications for Vaccine Recommendations Beyond Age. Open Forum Infectious Diseases. 12(7). ofaf394–ofaf394. 1 indexed citations

Walsh, Edward E., et al.. (2025). Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized With Respiratory Syncytial Virus. Clinical Infectious Diseases. 82(2). e396–e403. 3 indexed citations

Chu, Chin‐Yi, Ann R. Falsey, Derick R. Peterson, et al.. (2025). Clinical Features and Gene Expression Patterns in Adults Hospitalized With Respiratory Syncytial Virus and Human Metapneumovirus Infection. The Journal of Infectious Diseases. 232(Supplement_1). S37–S46. 1 indexed citations

Walsh, Edward E., et al.. (2025). P-718. Getting to the Heart of Respiratory Syncytial Virus Disease Burden. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Dobrzynski, David, Angela R Branche, & Ann R. Falsey. (2024). Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens. The Journal of Infectious Diseases. 231(2). 291–293.

Branche, Angela R, Mayur Ramesh, & Beverly M. Francis. (2024). A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection. Infectious Diseases and Therapy. 14(S1). 39–61. 9 indexed citations

Falsey, Ann R., et al.. (2023). Real-life Assessment of BioFire FilmArray Pneumonia Panel in Adults Hospitalized With Respiratory Illness. The Journal of Infectious Diseases. 229(1). 214–222. 22 indexed citations

Savic, Miloje, Yolanda Penders, Ting Shi, Angela R Branche, & Jean‐Yves Pirçon. (2022). Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis. Influenza and Other Respiratory Viruses. 17(1). e13031–e13031. 213 indexed citations breakdown →

10.

Richards, Katherine A., Florian Krammer, Francisco A. Chaves, et al.. (2022). The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History. The Journal of Infectious Diseases. 227(3). 381–390. 14 indexed citations

11.

Branche, Angela R, Lisa Saiman, Edward E. Walsh, et al.. (2022). Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Influenza and Other Respiratory Viruses. 16(6). 1151–1160. 41 indexed citations

12.

Peterson, Derick R., Andrea Baran, Soumyaroop Bhattacharya, et al.. (2021). Gene Expression Risk Scores for COVID-19 Illness Severity. The Journal of Infectious Diseases. 227(3). 322–331. 5 indexed citations

13.

Colombo, Christopher, Rhonda E Colombo, Ryan C. Maves, et al.. (2021). Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort. Critical Care Explorations. 3(7). e0474–e0474. 8 indexed citations

14.

Ganaie, Feroze, et al.. (2021). Effect of Oral Streptococci Expressing Pneumococcus-like Cross-Reactive Capsule Types on World Health Organization Recommended Pneumococcal Carriage Detection Procedure. Clinical Infectious Diseases. 75(4). 647–656. 10 indexed citations

15.

Gouma, Sigrid, Kangchon Kim, Madison E. Weirick, et al.. (2020). Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nature Communications. 11(1). 4566–4566. 45 indexed citations

16.

Drews, Steven J., Angela R Branche, Ann R. Falsey, & Nelson Lee. (2019). What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections?. Journal of Clinical Virology. 117. 27–32. 8 indexed citations

17.

Branche, Angela R, Hongmei Yang, James Java, et al.. (2018). Effect of prior vaccination on carriage rates of Streptococcus pneumoniae in older adults: A longitudinal surveillance study. Vaccine. 36(29). 4304–4310. 18 indexed citations

18.

Branche, Angela R & Ann R. Falsey. (2016). Parainfluenza Virus Infection. Seminars in Respiratory and Critical Care Medicine. 37(4). 538–554. 155 indexed citations

19.

Branche, Angela R, et al.. (2016). Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial. PLoS ONE. 11(4). e0152986–e0152986. 16 indexed citations

20.

Branche, Angela R, Edward E. Walsh, Roberto L. Vargas, et al.. (2015). Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial. The Journal of Infectious Diseases. 212(11). 1692–1700. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact